Clinical Trials Directory

Trials / Completed

CompletedNCT02618239

Effect of Prebiotics on Intestinal Gas Production, Microbiota and Digestive Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Non-absorbable, fermentable residues in the diet increase intestinal gas production and induce gas-related symptoms, such as flatulence, abdominal bloating and distention; however, prebiotics, which are also fermented by colonic bacteria have been shown to improve this type of symptoms. The aim is to demonstrate changes in metabolic activity of gut microbiota and colonic biomass induced by prebiotics. Healthy subjects (n=20) will be administered a prebiotic (Galacto-oligo-saccharide; 2.8 g/d) for 3 weeks; they will also receive a standard diet during three days. The following outcomes will be measured immediately before, at the beginning and at the end of the treatment: a) number of gas evacuations during daytime for 2 days on the standard diet, by means of an event marker; b) volume of gas evacuated via a rectal tube during 4 hours after a test meal, by means of a barostat; c) microbiota composition by fecal analysis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBimuno Galacto-oligo-saccharide

Timeline

Start date
2013-11-01
Primary completion
2014-04-01
Completion
2014-05-01
First posted
2015-12-01
Last updated
2015-12-01

Source: ClinicalTrials.gov record NCT02618239. Inclusion in this directory is not an endorsement.

Effect of Prebiotics on Intestinal Gas Production, Microbiota and Digestive Symptoms (NCT02618239) · Clinical Trials Directory